Hematology reportable test

Ended Awarded Last action

Contract number
W9114F22F0028
Awardee
Awarding agency
Obligated
$52,281

Award facts

Opportunity
Contract value 98% obligated
  • $52,280.84 Current, with exercised options
  • $53,213.85 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Germany

Award details come from SAM.gov/FPDS.

About this award

The Department of the Army Medical Command awarded a $53,213.85 firm fixed price delivery order to Sysmex Deutschland GMBH of Almanya for hematology reportable tests. The contract has no set-aside designation and runs through April 30, 2023. As the Army's medical research and development agency, the Medical Command supports Soldier health through clinical research and medical product acquisition. This delivery order will provide hematology testing services in support of the Command's patient care and clinical research missions.

Quick answers

Who was awarded contract W9114F22F0028?

W9114F22F0028 was awarded to Sysmex Deutschland GMBH by Medical Command (Department of the Army) on May 1, 2022.

How much is contract W9114F22F0028 worth?

The government has obligated $52,281 on W9114F22F0028. Its potential value, with all options, is $53,214.

Is contract W9114F22F0028 an order under another contract?

Yes. W9114F22F0028 is a delivery order under W9114F20D0004, an indefinite delivery contract.

Was contract W9114F22F0028 competed?

The extent of competition for W9114F22F0028 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award